Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology
Biotechnology · weight
3.38%
Industry change · 12M
+0.00 pp
Biotechnology · contribution
+0.000 pp
Company participation
0%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Jan 2018 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$179.2bn1.022%+0.000 pp+0.000 pp+0.0%No
Amgen →
AMGN
United States$135.1bn0.770%+0.000 pp+0.000 pp+0.0%No
Gilead Sciences →
GILD
United States$109.5bn0.624%+0.000 pp+0.000 pp+0.0%No
Biogen →
BIIB
United States$73.6bn0.420%+0.000 pp+0.000 pp+0.0%No
Vertex Pharmaceuticals →
VRTX
United States$42.2bn0.241%+0.000 pp+0.000 pp+0.0%No
Regeneron Pharmaceuticals →
REGN
United States$34.4bn0.196%+0.000 pp+0.000 pp+0.0%No
Incyte →
INCY
United States$19.1bn0.109%+0.000 pp+0.000 pp+0.0%No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.